Sarah Kalia

Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: A Practice Resource from the National Society of Genetic Counselors.

Wand H, Kalia SS, Helm BM, Suckiel SA, Brockman D, Vriesen N, Goudar RK, Austin J, Yanes T.

J Genet Couns. 2023 06. 32(3):558-575. PMID: 36617640

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.

Plym A, Penney KL, Kalia S, Kraft P, Conti DV, Haiman C, Mucci LA, Kibel AS.

J Natl Cancer Inst. 2022 05 09. 114(5):771-774. PMID: 33792693

Secondary findings: How did we get here, and where are we going?

Ormond KE, O'Daniel JM, Kalia SS.

J Genet Couns. 2019 04. 28(2):326-333. PMID: 30821867

Effect of communicating personalized rheumatoid arthritis risk on concern for developing RA: A randomized controlled trial.

Marshall AA, Zaccardelli A, Yu Z, Prado MG, Liu X, Miller Kroouze R, Kalia SS, Green RC, Triedman NA, Lu B, Deane KD, Iversen MD, Karlson EW, Sparks JA.

Patient Educ Couns. 2019 05. 102(5):976-983. PMID: 30558852

Effectiveness of a Web-Based Personalized Rheumatoid Arthritis Risk Tool With or Without a Health Educator for Knowledge of Rheumatoid Arthritis Risk Factors.

Prado MG, Iversen MD, Yu Z, Miller Kroouze R, Triedman NA, Kalia SS, Lu B, Green RC, Karlson EW, Sparks JA.

Arthritis Care Res (Hoboken). 2018 10. 70(10):1421-1430. PMID: 29316383

Disclosure of Personalized Rheumatoid Arthritis Risk Using Genetics, Biomarkers, and Lifestyle Factors to Motivate Health Behavior Improvements: A Randomized Controlled Trial.

Sparks JA, Iversen MD, Yu Z, Triedman NA, Prado MG, Miller Kroouze R, Kalia SS, Atkinson ML, Mody EA, Helfgott SM, Todd DJ, Dellaripa PF, Bermas BL, Costenbader KH, Deane KD, Lu B, Green RC, Karlson EW.

Arthritis Care Res (Hoboken). 2018 06. 70(6):823-833. PMID: 29024454

Social comparisons and quality of life following a prostate cancer diagnosis.

Umstead KL, Kalia SS, Madeo AC, Erby LH, Blank TO, Visvanathan K, Roter DL.

J Psychosoc Oncol. 2018 May-Jun. 36(3):350-363. PMID: 29424665

CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG.

Genet Med. 2017 05. 19(5):606. PMID: 28492529

Personal Genomic Testing for Cancer Risk: Results From the Impact of Personal Genomics Study.

Gray SW, Gollust SE, Carere DA, Chen CA, Cronin A, Kalia SS, Rana HQ, Ruffin MT, Wang C, Roberts JS, Green RC.

J Clin Oncol. 2017 Feb 20. 35(6):636-644. PMID: 27937091

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.

Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, Herman GE, Hufnagel SB, Klein TE, Korf BR, McKelvey KD, Ormond KE, Richards CS, Vlangos CN, Watson M, Martin CL, Miller DT.

Genet Med. 2017 02. 19(2):249-255. PMID: 27854360